Skip to main content
logo
Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
China flag China · Delayed Price · Currency is CNY
112.50
-0.50 (-0.44%)
Sep 12, 2025, 3:00 PM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Pharmaceuticals
531.53M
Log In
Log In
Log In
Log In
Upgrade
Pharmaceuticals Growth
38.58%
Log In
Log In
Log In
Log In
Upgrade
Technical Services
21.60M
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Intermediates and Raw Materials
1.33M
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Intermediates and Raw Materials Growth
-52.46%
Log In
Log In
Log In
Log In
Upgrade
Asset Licensing
91.74K
Log In
Log In
Log In
Log In
Upgrade
Asset Licensing Growth
20.00%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
China
532.95M
Log In
Log In
Log In
Log In
Upgrade
China Growth
37.91%
Log In
Log In
Log In
Log In
Upgrade
Overseas
-
Log In
Log In
Log In
Log In
Upgrade